Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562209710> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2562209710 abstract "Abstract Abstract 4110 Objective To study the proliferative inhibition of imatinib, daunorubicin and bortezomib in two kinds of Ph(+) leukemia cell lines: chronic myelogenous leukemia cell line K562 expressing P210 protein and acute lymphoblastic leukemia cell line SUP-B15 expressing P190 protein. Methods (1) Cell proliferation with imatinib, daunorubicin and bortezomib for 72 hours was analyzed by the MTT assay and displayed by growth curve and IC50 value. (2) The change of bcr-abl gene mRNA levels after the 48 hours' intervention of imatinib (final concentration at 0μM, 0.35μM, 1 μM) was detected by reverse transcription polymerase chain reaction (RT-PCR). Results (1) The IC50 values of K562 and SUP-B15 cells inhibited by imatinib, daunorubicin and bortezomib for 72 hours was respectively 0.286±0.06 (μmol/L), 0.303±0.009 (μmol/L), 22.127±3.592 (nmol/L) and 1.387±0.180(μmol/L), 0.117±0.017 (μmol/L), 12.350±0.740 (nmol/L), which indicated that the K562 cell line was the more sensitive to imatinib than SUP-B15 cell line, whereas the SUP-B15 cell line had the more sensitivity to daunorubicin and bortezomib. (2) There was no change of bcr-abl gene expression after the 48 hours' intervention of imatinib in both cell lines. Conclusion (1) Imatinib, daunorubicin and bortezomib had good anti-cancer effect to Ph+ leukemia cells in vitro. What's more, the K562 cell was the more sensitive to imatinib and only imatinib will have good effect on chronic myelogenous leukemia. Whereas the SUP-B15 cell had the more sensitivity to daunorubicin and bortezomib and combining imatinib with daunorubicin or bortezomib, the effect will be better on Ph(+) acute lymphoblastic leukemia. (2) The short time intervention of imatinib had no effect on the bcr-abl gene expression and imatinib could need long time to show curative effect for the Ph+ leukemia. Disclosures: No relevant conflicts of interest to declare." @default.
- W2562209710 created "2017-01-06" @default.
- W2562209710 creator A5044053690 @default.
- W2562209710 creator A5060327949 @default.
- W2562209710 creator A5077666079 @default.
- W2562209710 date "2009-11-20" @default.
- W2562209710 modified "2023-09-26" @default.
- W2562209710 title "To Study the Proliferative Inhibition of Anticancer Drug in Two Kinds of Ph (+) Leukemia Cell Lines." @default.
- W2562209710 doi "https://doi.org/10.1182/blood.v114.22.4110.4110" @default.
- W2562209710 hasPublicationYear "2009" @default.
- W2562209710 type Work @default.
- W2562209710 sameAs 2562209710 @default.
- W2562209710 citedByCount "0" @default.
- W2562209710 crossrefType "journal-article" @default.
- W2562209710 hasAuthorship W2562209710A5044053690 @default.
- W2562209710 hasAuthorship W2562209710A5060327949 @default.
- W2562209710 hasAuthorship W2562209710A5077666079 @default.
- W2562209710 hasConcept C125418893 @default.
- W2562209710 hasConcept C126322002 @default.
- W2562209710 hasConcept C153911025 @default.
- W2562209710 hasConcept C170493617 @default.
- W2562209710 hasConcept C171122931 @default.
- W2562209710 hasConcept C185592680 @default.
- W2562209710 hasConcept C203014093 @default.
- W2562209710 hasConcept C2776364478 @default.
- W2562209710 hasConcept C2776960273 @default.
- W2562209710 hasConcept C2777478702 @default.
- W2562209710 hasConcept C2777583451 @default.
- W2562209710 hasConcept C2778461978 @default.
- W2562209710 hasConcept C2778729363 @default.
- W2562209710 hasConcept C2781021840 @default.
- W2562209710 hasConcept C3019892230 @default.
- W2562209710 hasConcept C42362537 @default.
- W2562209710 hasConcept C502942594 @default.
- W2562209710 hasConcept C54355233 @default.
- W2562209710 hasConcept C55493867 @default.
- W2562209710 hasConcept C62112901 @default.
- W2562209710 hasConcept C71924100 @default.
- W2562209710 hasConcept C81885089 @default.
- W2562209710 hasConcept C86803240 @default.
- W2562209710 hasConcept C98274493 @default.
- W2562209710 hasConceptScore W2562209710C125418893 @default.
- W2562209710 hasConceptScore W2562209710C126322002 @default.
- W2562209710 hasConceptScore W2562209710C153911025 @default.
- W2562209710 hasConceptScore W2562209710C170493617 @default.
- W2562209710 hasConceptScore W2562209710C171122931 @default.
- W2562209710 hasConceptScore W2562209710C185592680 @default.
- W2562209710 hasConceptScore W2562209710C203014093 @default.
- W2562209710 hasConceptScore W2562209710C2776364478 @default.
- W2562209710 hasConceptScore W2562209710C2776960273 @default.
- W2562209710 hasConceptScore W2562209710C2777478702 @default.
- W2562209710 hasConceptScore W2562209710C2777583451 @default.
- W2562209710 hasConceptScore W2562209710C2778461978 @default.
- W2562209710 hasConceptScore W2562209710C2778729363 @default.
- W2562209710 hasConceptScore W2562209710C2781021840 @default.
- W2562209710 hasConceptScore W2562209710C3019892230 @default.
- W2562209710 hasConceptScore W2562209710C42362537 @default.
- W2562209710 hasConceptScore W2562209710C502942594 @default.
- W2562209710 hasConceptScore W2562209710C54355233 @default.
- W2562209710 hasConceptScore W2562209710C55493867 @default.
- W2562209710 hasConceptScore W2562209710C62112901 @default.
- W2562209710 hasConceptScore W2562209710C71924100 @default.
- W2562209710 hasConceptScore W2562209710C81885089 @default.
- W2562209710 hasConceptScore W2562209710C86803240 @default.
- W2562209710 hasConceptScore W2562209710C98274493 @default.
- W2562209710 hasLocation W25622097101 @default.
- W2562209710 hasOpenAccess W2562209710 @default.
- W2562209710 hasPrimaryLocation W25622097101 @default.
- W2562209710 hasRelatedWork W2070103350 @default.
- W2562209710 hasRelatedWork W2134288099 @default.
- W2562209710 hasRelatedWork W2166687484 @default.
- W2562209710 hasRelatedWork W2365026743 @default.
- W2562209710 hasRelatedWork W2371530266 @default.
- W2562209710 hasRelatedWork W2385410559 @default.
- W2562209710 hasRelatedWork W2529971935 @default.
- W2562209710 hasRelatedWork W2535395627 @default.
- W2562209710 hasRelatedWork W2557051291 @default.
- W2562209710 hasRelatedWork W2559877690 @default.
- W2562209710 hasRelatedWork W2561264952 @default.
- W2562209710 hasRelatedWork W2570169929 @default.
- W2562209710 hasRelatedWork W2574067943 @default.
- W2562209710 hasRelatedWork W2578953974 @default.
- W2562209710 hasRelatedWork W2581808590 @default.
- W2562209710 hasRelatedWork W2581890175 @default.
- W2562209710 hasRelatedWork W2589282569 @default.
- W2562209710 hasRelatedWork W2927945251 @default.
- W2562209710 hasRelatedWork W3030533539 @default.
- W2562209710 hasRelatedWork W3143928351 @default.
- W2562209710 isParatext "false" @default.
- W2562209710 isRetracted "false" @default.
- W2562209710 magId "2562209710" @default.
- W2562209710 workType "article" @default.